Global Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Jul 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Prescription Digital Therapeutics (PDTx) Market, By Mechanism (Input Mechanisms, Output Mechanisms), Category (Medication Augmentation, Medication Replacement), Treatment (Outpatient Treatment, Monotherapy), Software (Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes, Others), Services (Behavioral Microservices, Medical Microservices), App Accessibility (Android, iOS, Windows), App Type (Native Apps, Web Apps), Application (Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others), Patients (Children, Adults), and Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

 

Prescription Digital Therapeutics (PDTx) Market Market Analysis and Insights : Global Prescription Digital Therapeutics (PDTx) Market

The prescription digital therapeutics (PDTx) market is expected to witness market growth at a rate of 11.20% in the forecast period of 2021 to 2028. Data Bridge Market Research report on prescription digital therapeutics (PDTx) market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the research and clinical studies is escalating the growth of prescription digital therapeutics (PDTx) market.

Prescription digital therapeutics can be referred to as a novel treatment method that permits the software implementations to promptly treat serious disease. It is intended in such way that it provides evidence-based treatment anywhere and anytime and even offering clinicians with real-time data on patient progress.

Major factors that are expected to boost the growth of the prescription digital therapeutics (PDTx) market in the forecast period are the rise in the incidence of disease around the world. Furthermore, the increase in the governing agreements for the digital therapeutics by the governing authorities is further estimated to cushion the growth of the prescription digital therapeutics (PDTx) market. On the other hand, the unaffordability of the digital therapeutics is further projected to impede the growth of the prescription digital therapeutics (PDTx) market in the timeline period.

In addition, the rise in the need because of their high expense efficiency will further provide potential opportunities for the growth of the prescription digital therapeutics (PDTx) market in the coming years. However, the dearth of the healthcare budget in few middle-income countries might further challenge the growth of the prescription digital therapeutics (PDTx) market in the near future.

The prescription digital therapeutics (PDTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the prescription digital therapeutics (PDTx) market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Prescription Digital Therapeutics (PDTx) Market Scope and Market Size

The prescription digital therapeutics (PDTx) market is segmented on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of mechanism, the prescription digital therapeutics (PDTx) market is segmented into input mechanisms and output mechanisms.
  • On the basis of category, the prescription digital therapeutics (PDTx) market is segmented into medication augmentation and medication replacement.
  • On the basis of treatment, the prescription digital therapeutics (PDTx) market is segmented into outpatient treatment and monotherapy.
  • On the basis of software, the prescription digital therapeutics (PDTx) market is segmented into software for respiratory conditions, software for mental health, software for opioid use disorder, software for diabetes and others.
  • On the basis of services, the prescription digital therapeutics (PDTx) market is segmented into behavioral microservices and medical microservices.
  • On the basis of app accessibility, the prescription digital therapeutics (PDTx) market is segmented into android, iOS and windows.
  • On the basis of app type, the prescription digital therapeutics (PDTx) market is segmented into native app and web app.
  • On the basis of application, the prescription digital therapeutics (PDTx) market is segmented into substance use disorder (SUD), opioid use disorder (OUD), attention deficit/hyperactivity disorder (ADHD), alzheimer’s disease, major depressive disorder (MDD), insomnia, epilepsy, movement disorder, multiple sclerosis, migraine, autism spectrum disorder, oncology, inflammation, respiratory, cardiovascular, pain management, metabolic conditions and others.
  • On the basis of patients, the prescription digital therapeutics (PDTx) market is segmented into children and adults.

Prescription Digital Therapeutics (PDTx) Market Country Level Analysis

The prescription digital therapeutics (PDTx) market is analysed and market size information is provided by country, mechanism, category, treatment, software, services, app accessibility, app type, application and patients as referenced above.

The countries covered in the prescription digital therapeutics (PDTx) market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the prescription digital therapeutics (PDTx) market due to the rise in the research and development going on the prescription digital therapeutics (PDTx). Furthermore, the influx of new start-ups will further boost the growth of the prescription digital therapeutics (PDTx) market in the region during the forecast period. Europe is projected to observe significant amount of growth in the prescription digital therapeutics (PDTx) market due to the advancements in the reimbursement structure for the digital therapeutics. Moreover, the initiatives taken by the government to support technological advancements is further anticipated to propel the growth of the prescription digital therapeutics (PDTx) market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The prescription digital therapeutics (PDTx) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Prescription Digital Therapeutics (PDTx) Market Share Analysis

The prescription digital therapeutics (PDTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to prescription digital therapeutics (PDTx) market.

The major players covered in the prescription digital therapeutics (PDTx) market report are Omada Health, Inc., ResMed, SAMSUNG, GAIA AG, Pear Therapeutics, Inc., Welldoc’s Bluestar, Solera Network, Akili Interactive Labs, Inc., Better Therapeutics, LLC, BigHealth, Biofourmis, Click Therapeutics, Inc., Happify, Inc., Limbix Health, Inc., Naturalcycles Nordic AB, NuvoAir AB, Sensyne Health plc, Voluntis and Xealth among other domestic and global players. The prescription digital therapeutics (PDTx) market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Prescription Digital Therapeutics (PDTx) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions